Karin Jirström
251 – 341 of 341
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2011
-
Mark
RBM3-Regulated Genes Promote DNA Integrity and Affect Clinical Outcome in Epithelial Ovarian Cancer.
(
- Contribution to journal › Article
-
Mark
Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer
(
- Contribution to journal › Article
-
Mark
The emerging role of FK506-binding proteins as cancer biomarkers: a focus on FKBPL
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition
(
- Contribution to journal › Article
-
Mark
Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
(
- Contribution to journal › Article
-
Mark
Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
(
- Contribution to journal › Article
-
Mark
Cysteinyl leukotriene receptor expression pattern affects migration of breast cancer cells and survival of breast cancer patients.
(
- Contribution to journal › Article
-
Mark
Anthropometric factors and ovarian cancer risk in the Malmö Diet and Cancer Study.
(
- Contribution to journal › Article
-
Mark
Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer.
(
- Contribution to journal › Article
-
Mark
Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen.
(
- Contribution to journal › Article
-
Mark
Isolation and characterization of progenitor-like cells from human renal proximal tubules.
(
- Contribution to journal › Article
-
Mark
SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal Carcinomas.
(
- Contribution to journal › Article
-
Mark
A non-functional retinoblastoma tumor suppressor (RB) pathway in premenopausal breast cancer is associated with resistance to tamoxifen.
(
- Contribution to journal › Article
-
Mark
Chondroitin sulfate expression predicts poor outcome in breast cancer.
(
- Contribution to journal › Article
-
Mark
High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression.
(
- Contribution to journal › Article
-
Mark
P4-09-02: G Protein-Coupled Estrogen Receptor 1 Positively Correlates with Estrogen Receptor a Expression and Increased Distant Disease-Free Survival of Breast Cancer Patients.
(
- Contribution to journal › Published meeting abstract
- 2010
-
Mark
HMG-CoAR is an Independent Predictor of Recurrence Free Survival in Epithelial Ovarian Cancer
2010) Annual Meeting of the Blair Bell Society In BJOG: An International Journal of Obstetrics & Gynaecology 117(5). p.623-623(
- Contribution to journal › Published meeting abstract
-
Mark
Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study
(
- Contribution to journal › Article
-
Mark
Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancer
(
- Contribution to journal › Article
-
Mark
Increased androgen receptor expression in serous carcinoma of the ovary is associated with an improved survival
(
- Contribution to journal › Article
-
Mark
PKC alpha expression is a marker for breast cancer aggressiveness
(
- Contribution to journal › Article
-
Mark
Validation study of the prognostic significance of beta-microseminoprotein and cysteine-rich secretory protein-3 after radical prostatectomy using automated image analysis
2010) 21st Meeting of the European-Association-for-Cancer-Research In EJC Supplements 8(5). p.136-136(
- Contribution to journal › Published meeting abstract
-
Mark
Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer
(
- Contribution to journal › Article
-
Mark
STROMA-DERIVED MARKERS PREDICTING BREAST CANCER PROGNOSIS AND TREATMENT RESPONSE
(
- Contribution to journal › Published meeting abstract
-
Mark
Receptor Tyrosine Kinase Signaling Favors a Protumorigenic State in Breast Cancer Cells by Inhibiting the Adaptive Immune Response
(
- Contribution to journal › Article
-
Mark
Up-regulation of cell cycle arrest protein BTG2 correlates with increased overall survival in breast cancer, as detected by immunohistochemistry using tissue microarray
(
- Contribution to journal › Article
-
Mark
Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer
(
- Contribution to journal › Article
-
Mark
Plasma Folate Concentrations Are Positively Associated with Risk of Estrogen Receptor {beta} Negative Breast Cancer in a Swedish Nested Case Control Study.
(
- Contribution to journal › Article
-
Mark
Expression of the translation regulatory protein RBM3 is associated with a favourable prognosis in epithelial ovarian cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
Homeobox transcription factor muscle segment homeobox 2 (Msx2) correlates with good prognosis in breast cancer patients and induces apoptosis in vitro
(
- Contribution to journal › Article
-
Mark
Polymorphisms in fatty acid metabolism-related genes are associated with colorectal cancer risk
(
- Contribution to journal › Article
-
Mark
Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition
(
- Contribution to journal › Article
-
Mark
p27(Kip1) is a predictive factor for tamoxifen treatment response but not a prognostic marker in premenopausal breast cancer patients.
(
- Contribution to journal › Article
-
Mark
Immunohistochemical detection of tyrosine phosphatase SHP-1 predicts outcome after radical prostatectomy for localized prostate cancer.
(
- Contribution to journal › Article
-
Mark
Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up.
(
- Contribution to journal › Article
-
Mark
Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohort.
(
- Contribution to journal › Article
-
Mark
Down-Regulation of the Oncogene Cyclin D1 Increases Migratory Capacity in Breast Cancer and Is Linked to Unfavorable Prognostic Features.
(
- Contribution to journal › Article
-
Mark
Forkhead box F1 regulates tumor-promoting properties of cancer-associated fibroblasts in lung cancer.
(
- Contribution to journal › Article
-
Mark
Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients.
(
- Contribution to journal › Article
-
Mark
Modeling Prognostic Markers in Breast Cancer — Are We Using Them the Optimal Way?
(
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
The transcription factor Sox11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancer
(
- Contribution to journal › Article
-
Mark
Long-Term Survival of Breast Ductal Carcinoma In Situ in Women with Different Gene-Expression Types.
(
- Contribution to journal › Published meeting abstract
-
Mark
Prognostic Significance of Stromal Platelet-Derived Growth Factor beta-Receptor Expression in Human Breast Cancer
(
- Contribution to journal › Article
-
Mark
Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer
(
- Contribution to journal › Article
-
Mark
JAM-A expression positively correlates with poor prognosis in breast cancer patients
(
- Contribution to journal › Article
-
Mark
Differential expression of cytoplasmic and stromal beta-arrestin-1 is associated with separate aspects of tumor behavior in breast cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
DEVELOPMENT OF IMMUNOHISTOCHEMICAL SURROGATES FOR PREDICTION OF BREAST CANCER PATIENT OUTCOME VIA HIGH-THROUGHPUT ANTIBODY GENERATION AND APPLICATION OF TISSUE MICROARRAY TECHNOLOGY: AN INITIAL REPORT
(
- Contribution to journal › Published meeting abstract
-
Mark
Vascular endothelial growth factor receptor 2 is a significant negative prognostic biomarker in triple-negative breast cancer: results from a controlled randomised trial of premenopausal breast cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
CRIM1 is localized to the podocyte filtration slit diaphragm of the adult human kidney
(
- Contribution to journal › Article
-
Mark
SOX11 but not SOX4 is a prognostic marker for improved recurrence free survival in epithelial ovarian cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
Molecular evolution of specific human antibody against MUC1 mucin results in improved recognition of the antigen on tumour cells
(
- Contribution to journal › Article
-
Mark
The Prognostic Significance of Tryptophanyl-tRNA Synthetase in Colorectal Cancer
(
- Contribution to journal › Article
-
Mark
Erythropoietin Receptor Expression and Correlation to Tamoxifen Response and Prognosis in Breast Cancer.
(
- Contribution to journal › Article
-
Mark
Anthropometric factors in relation to different tumor biological subgroups of postmenopausal breast cancer.
(
- Contribution to journal › Article
-
Mark
Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer.
2009) In Modern Pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 22. p.1564-1574(
- Contribution to journal › Article
-
Mark
Cyclin A Is a Proliferative Marker with Good Prognostic Value in Node-Negative Breast Cancer.
2009) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 18. p.2501-2506(
- Contribution to journal › Article
-
Mark
High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer.
(
- Contribution to journal › Article
- 2008
-
Mark
Oestrogen receptor beta immunohistochemistry: time to get it right? Authors' response
(
- Contribution to journal › Letter
-
Mark
Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer.
(
- Contribution to journal › Article
-
Mark
Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer
(
- Contribution to journal › Article
-
Mark
Nuclear expression of the Non-B Cell Lineage Sox11 Transcription Factor Identifies Mantle Cell Lymphoma
(
- Contribution to journal › Article
-
Mark
Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer
(
- Contribution to journal › Article
-
Mark
15-Prostaglandin Dehydrogenase Expression Alone or in Combination with ACSM1 Defines a Subgroup of the Apocrine Molecular Subtype of Breast Carcinoma
(
- Contribution to journal › Article
-
Mark
Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer
(
- Contribution to journal › Article
-
Mark
Quality aspects of the tissue microarray technique in a population-based cohort with ductal carcinoma in situ of the breast
(
- Contribution to journal › Article
-
Mark
The Human Protein Atlas - a tool for pathology
(
- Contribution to journal › Letter
-
Mark
Sox11, a non-B cell lineage transcription factor, is overexpressed in mantle cell lymphoma
2008) 10th International Conference on Malignant Lymphoma In Annals of Oncology 19(Suppl. 4). p.172-173(
- Contribution to journal › Published meeting abstract
-
Mark
Epidermal growth factor receptor expression in 334 non small cell lung carcinoma patients; prognosis and correlation between gene copy number and protein expression
2008) 3rd Intercontinental Congress of Pathology In Virchows Archiv: an international journal of pathology 452(Suppl. 1). p.3-3(
- Contribution to journal › Published meeting abstract
-
Mark
Systematic validation of novel breast cancer progression-associated biomarkers via high-throughput antibody generation and application of tissue microarray technology
2008) EBCC-6, European Breast Cancer Conference, 2008 In European Journal of Cancer Supplements 6(7). p.59-59(
- Contribution to journal › Published meeting abstract
-
Mark
Cyclin E confers a prognostic value in premenopausal breast cancer patients with tumours exhibiting an infiltrative growth pattern.
(
- Contribution to journal › Article
-
Mark
HMG-CoA reductase expression in breast cancer is associated with a less aggressive phenotype and influenced by anthropometric factors.
(
- Contribution to journal › Article
-
Mark
Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer.
(
- Contribution to journal › Article
- 2007
-
Mark
Breast tumours following combined hormone replacement therapy express favourable prognostic factors.
(
- Contribution to journal › Article
-
Mark
Quantitative measurement of epidermal growth factor receptor is a negative predictive factor for tamoxifen response in hormone receptor - Positive premenopausal breast cancer
(
- Contribution to journal › Article
-
Mark
CENP-F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancer
(
- Contribution to journal › Article
-
Mark
Diet and body constitution in relation to sub-groups of breast cancer defined by tumour grade, proliferation and key cell cycle regulators.
(
- Contribution to journal › Article
-
Mark
Expression of the cytoskeleton linker protein ezrin in human cancers
(
- Contribution to journal › Article
- 2006
-
Mark
CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance
(
- Contribution to journal › Article
-
Mark
Classification of breast cancer using genetic algorithms and tissue microarrays
(
- Contribution to journal › Article
-
Mark
Hypoxia inducible factor-1alpha is a prognostic marker in premenopausal patients with intermediate to highly differentiated breast cancer but not a predictive marker for tamoxifen response.
(
- Contribution to journal › Article
-
Mark
Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients.
(
- Contribution to journal › Article
-
Mark
High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients.
(
- Contribution to journal › Article
- 2005
-
Mark
ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis
(
- Contribution to journal › Article
-
Mark
Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer.
(
- Contribution to journal › Article
-
Mark
Adverse effect of adjuvant tamoxifen in premenopausal breast cancer with cyclin D1 gene amplification.
(
- Contribution to journal › Article
-
Mark
Cyclin I is expressed in human breast cancer and closely associated with VEGF and KDR expression.
(
- Contribution to journal › Article
-
Mark
Two years of adjuvant tamoxifen in premenopausal patients with breast cancer: a randomised, controlled trial with long-term follow-up.
(
- Contribution to journal › Article
-
Mark
TISSUE MICROARRAY PERSPECTIVES ON CYCLIN D1 IN BREAST CANCER: Progression, prognosis and prediction
2005)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Pathology parameters and adjuvant tamoxifen response in a randomised premenopausal breast cancer trial.
(
- Contribution to journal › Article
-
Mark
Cyclin E overexpression obstructs infiltrative behavior in breast cancer: a novel role reflected in the growth pattern of medullary breast cancers.
(
- Contribution to journal › Article
- 2003
-
Mark
Tissue microarray analyses of G1/S-regulatory proteins in ductal carcinoma in situ of the breast indicate that low cyclin D1 is associated with local recurrence.
(
- Contribution to journal › Article
- « previous
- 1
- 2
- next »